MEMPHIS, Tenn.--(BUSINESS WIRE)-- GTx, Inc. (NASDAQ: GTXI) announced today that Dr. Mitchell S. Steiner, CEO, is scheduled to participate in a panel discussion on the topic “Finally, Lots of Options for Treating Prostate Cancer ” at Citi’s 6th Annual Biotech Day on Wednesday, September 7, 2011, at 11:00 a.m. ET. The conference will be held at the Ritz Carlton hotel in Boston, Massachusetts.
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions.
McDavid Stilwell, 901-523-9700
Director, Corporate Communications & Financial Analysis
KEYWORDS: United States North America Massachusetts Tennessee
INDUSTRY KEYWORDS: Health Biotechnology Consumer General Health Men